Robert Mauch Biography and Net Worth

COO of Cencora

Dr. Robert P. Mauch Ph.D. serves as Executive Vice President and Group President of the Company. He served as President, AmerisourceBergen Drug Corporation from February 2015 to June 2017. Mr. Mauch previously served as Senior Vice President Chief Operating Officer, AmerisourceBergen Drug Corporation from March 2014 to February 2015. He was Senior Vice President, Operations, AmerisourceBergen Drug Corporation from April 2012 to March 2014. He was Senior Vice President of Sales and Marketing, AmerisourceBergen Drug Corporation from April 2011 to April 2012. He was Senior Vice President, Alternate Care Sales and Marketing, AmerisourceBergen Drug Corporation from May 2010 to April 2011. Mr. Mauch has been employed by the Company or one of its predecessors for 25 years.

What is Robert P. Mauch's net worth?: The estimated net worth of Robert P. Mauch is at least $6.10 million as of April 15th, 2024. Dr. Mauch owns 24,412 shares of Cencora stock worth more than $6,100,559 as of December 3rd. This net worth approximation does not reflect any other assets that Dr. Mauch may own. Additionally, Dr. Mauch receives a salary of $2,700,000.00 as COO at Cencora. Learn More about Robert P. Mauch's net worth.
How old is Robert P. Mauch?: Dr. Mauch is currently 57 years old. There are 7 older executives and no younger executives at Cencora. The oldest executive at Cencora is Ms. Gina K. Clark, Executive VP and Chief Communications & Administration Officer, who is 67 years old. Learn More on Robert P. Mauch's age.
What is Robert P. Mauch's salary?: As the COO of Cencora, Inc., Dr. Mauch earns $2,700,000.00 per year. The highest earning executive at Cencora is Mr. Steven H. Collis, Chairman, President & CEO, who commands a salary of $5,010,000.00 per year. Learn More on Robert P. Mauch's salary.
How do I contact Robert P. Mauch?: The corporate mailing address for Dr. Mauch and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Robert P. Mauch's contact information.
Has Robert P. Mauch been buying or selling shares of Cencora?: Robert P. Mauch has not been actively trading shares of Cencora during the last quarter. Most recently, Robert P. Mauch sold 57,564 shares of the business's stock in a transaction on Monday, April 15th. The shares were sold at an average price of $235.09, for a transaction totalling $13,532,720.76. Following the completion of the sale, the chief operating officer now directly owns 24,412 shares of the company's stock, valued at $5,739,017.08. Learn More on Robert P. Mauch's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 16 times. They sold a total of 10,748,964 shares worth more than $2,514,519,586.19. The most recent insider tranaction occured on November, 25th when Chairman Steven H Collis sold 50,000 shares worth more than $12,198,500.00. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 11/25/2024.

Robert P. Mauch Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/15/2024	Sell	57,564	$235.09	$13,532,720.76	24,412
11/4/2022	Sell	21,802	$160.00	$3,488,320.00	20,197
2/1/2022	Sell	44,492	$137.04	$6,097,183.68
11/2/2021	Sell	41,214	$125.34	$5,165,762.76
1/6/2021	Sell	16,561	$105.06	$1,739,898.66	38,363
12/14/2020	Sell	77,560	$98.02	$7,602,431.20	99,362
8/20/2020	Sell	5,262	$101.72	$535,250.64	28,091
7/20/2020	Sell	5,262	$104.40	$549,352.80	28,091
6/19/2020	Sell	5,262	$102.00	$536,724.00	28,091
5/20/2020	Sell	5,262	$90.00	$473,580.00	28,091
4/20/2020	Sell	5,262	$90.00	$473,580.00	28,091
3/31/2020	Sell	5,263	$90.00	$473,670.00	28,092
5/28/2019	Sell	24,767	$81.16	$2,010,089.72	43,286
6/13/2018	Sell	1,000	$90.00	$90,000.00
4/30/2018	Sell	1,000	$93.28	$93,280.00	13,123
4/17/2018	Sell	1,000	$90.00	$90,000.00	13,123
2/28/2018	Sell	1,000	$97.94	$97,940.00
12/14/2017	Sell	3,000	$90.00	$270,000.00	14,531
2/27/2015	Sell	19,415	$102.79	$1,995,667.85

Robert P. Mauch Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $250.60

$249.83

$252.40

50 Day Range

MA: $235.35

$219.50

$251.60

2 Week Range

Now: $250.60

$195.83

$253.27

Volume

254,312 shs

Average Volume

1,388,388 shs

Market Capitalization

$49.38 billion

P/E Ratio

33.37

Dividend Yield

0.87%

Beta

0.45

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Robert Mauch Biography and Net Worth

What is Robert P. Mauch's net worth?

How old is Robert P. Mauch?

What is Robert P. Mauch's salary?

How do I contact Robert P. Mauch?

Has Robert P. Mauch been buying or selling shares of Cencora?

Who are Cencora's active insiders?

Are insiders buying or selling shares of Cencora?